+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
ID06283888

Safety and Effectiveness of CYP2C19 Genotype-Guided P2Y12 Inhibitor Therapy Compared to Standard Treatment After Complex Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients

Led by Zunyi Medical College · Updated on 2024-03-20

1200

Participants Needed

1

Research Sites

34 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of selecting P2Y12 receptor inhibitors based on CYP2C19 genetic testing compared to conventional antiplatelet therapy in Chinese patients with acute coronary syndrome ACS undergoing complex percutaneous coronary intervention PCI. This trial aims to find the best balance between preventing blood clots and reducing bleeding risks by tailoring medication choices guided by a patients genetics. Participants will initially receive dual antiplatelet therapy DAPT with either ticagrelor or clopidogrel plus aspirin before PCI. After PCI, patients are randomly assigned to a genotype-guided group, where treatment depends on their CYP2C19 gene variant ticagrelor or clopidogrel plus aspirin for 3 months, or a conventional group receiving standard DAPT. Following 3 months, both groups continue with a single P2Y12 inhibitor either ticagrelor or clopidogrel without aspirin for an additional 9 months. Throughout the 12-month study, participants will be monitored for net adverse clinical events, including cardiac death, heart attacks, vessel revascularization, stroke, and significant bleeding. Researchers will assess safety and effectiveness through clinical evaluations and follow-ups. Participants will provide a DNA sample for genotyping and attend regular visits to track their health and treatment outcomes under medical supervision.

CONDITIONS

Brief Title

CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention

Research Team

C

Cai De Jin, MD

Y

Yan Yan Jin, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here